Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Mortality Risk in IgA Nephropathy.

Glassock RJ.

J Am Soc Nephrol. 2019 May;30(5):720-722. doi: 10.1681/ASN.2018121255. Epub 2019 Apr 10. No abstract available.

PMID:
31040186
2.

Prevention of complications from use of conventional immunosuppressants: a critical review.

Ponticelli C, Glassock RJ.

J Nephrol. 2019 Mar 29. doi: 10.1007/s40620-019-00602-5. [Epub ahead of print] Review.

PMID:
30927190
3.

Evaluation of living donors: quo vadis for GFR criteria?

Glassock RJ.

Kidney Int. 2019 Apr;95(4):738-740. doi: 10.1016/j.kint.2019.01.015.

PMID:
30904061
4.

Albuminuria: a target for clinical trials in kidney disease?

Glassock RJ.

Nat Rev Nephrol. 2019 May;15(5):257-258. doi: 10.1038/s41581-019-0123-x. No abstract available.

PMID:
30765852
5.

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants.

Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008.

6.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants.

Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018.

PMID:
30665568
7.

Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

De Vriese AS, Sethi S, Nath KA, Glassock RJ, Fervenza FC.

J Am Soc Nephrol. 2018 Mar;29(3):759-774. doi: 10.1681/ASN.2017090958. Epub 2018 Jan 10.

8.

A future for nephrology?

Glassock R.

J Bras Nefrol. 2017 Oct-Dec;39(4):486-490. doi: 10.5935/0101-2800.20170087. English, Portuguese.

9.

Donation, Not Disease! A Multiple-Hit Hypothesis on Development of Post-Donation Kidney Disease.

Cheng XS, Glassock RJ, Lentine KL, Chertow GM, Tan JC.

Curr Transplant Rep. 2017;4(4):320-326. doi: 10.1007/s40472-017-0171-8. Epub 2017 Nov 4. Review.

10.

Chronic kidney disease.

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ.

Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88. Review.

PMID:
29168475
11.

Reply to Letter to the Editor.

Glassock RJ, Denic A, Rule AD.

J Bras Nefrol. 2017 Jul-Sep;39(3):347-348. doi: 10.5935/0101-2800.20170061. English, Portuguese. No abstract available.

12.

Data on the relation between renal biomarkers and measured glomerular filtration rate.

Pottel H, Dubourg L, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Bevc S, Delanaye P, Ebert N.

Data Brief. 2017 Sep 1;14:763-772. doi: 10.1016/j.dib.2017.08.034. eCollection 2017 Oct.

13.

Single-Nephron Glomerular Filtration Rate in Healthy Adults.

Denic A, Glassock RJ, Rule AD.

N Engl J Med. 2017 Sep 21;377(12):1203-4. doi: 10.1056/NEJMc1709128. No abstract available.

PMID:
28930503
14.

Structural and Functional Changes in Human Kidneys with Healthy Aging.

Hommos MS, Glassock RJ, Rule AD.

J Am Soc Nephrol. 2017 Oct;28(10):2838-2844. doi: 10.1681/ASN.2017040421. Epub 2017 Aug 8. Review.

15.

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V; TESTING Study Group.

JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.

16.

Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Yu F, Haas M, Glassock R, Zhao MH.

Nat Rev Nephrol. 2017 Aug;13(8):483-495. doi: 10.1038/nrneph.2017.85. Epub 2017 Jul 3. Review.

PMID:
28669995
17.

Epidemiology of chronic kidney disease: think (at least) twice!

Delanaye P, Glassock RJ, De Broe ME.

Clin Kidney J. 2017 Jun;10(3):370-374. doi: 10.1093/ckj/sfw154. Epub 2017 Feb 27.

18.

Single-Nephron Glomerular Filtration Rate in Healthy Adults.

Denic A, Mathew J, Lerman LO, Lieske JC, Larson JJ, Alexander MP, Poggio E, Glassock RJ, Rule AD.

N Engl J Med. 2017 Jun 15;376(24):2349-2357. doi: 10.1056/NEJMoa1614329.

19.

Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.

Musso CG, Juarez R, Glassock RJ.

Int Urol Nephrol. 2018 Jan;50(1):81-89. doi: 10.1007/s11255-017-1614-y. Epub 2017 Jun 12. Review.

PMID:
28608260
20.

The diagnostic value of rescaled renal biomarkers serum creatinine and serum cystatin C and their relation with measured glomerular filtration rate.

Pottel H, Dubourg L, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Bevc S, Delanaye P, Ebert N.

Clin Chim Acta. 2017 Aug;471:164-170. doi: 10.1016/j.cca.2017.06.005. Epub 2017 Jun 7.

Supplemental Content

Loading ...
Support Center